• As a leading innovator in brain diagnostics technology, BRSF appears well placed to spot and predict driving forces behind the industry’s expected rapid growth
• BRSF’s Marketing Director was featured in an article giving prediction about key trends driving brain monitoring space in 2021
• BRSF poised to remain at EEG forefront as exciting new opportunities lay ahead for this growing sector

Recognized as a leading innovative player in the brain monitoring space, Brain Scientific (OTCQB: BRSF) continues to be at the forefront of what is next in neurology technology. The Company’s Marketing Director, Irina Nazarova, was featured in Tech Times, a publication reporting on the latest innovations and developments in technology, science, and health industries, where she outlined key brain monitoring trends to watch in 2021 (https://ibn.fm/txDqZ). Technology is advancing at an accelerated rate, pushing boundaries on what is possible and at what costs across neurology medical devices. As a result, brain monitoring is becoming as popular and widespread as monitoring pulse or heart rate, Nazarova notes. With technology becoming ever more ubiquitous, one of the key trends involves cross-industry cooperation and expansion into new markets. For example, EEG coupled with virtual reality technology has enabled the development of the so-called brain-computer interface (“BCI”). This VR neuro interface activates a direct communication pathway between a user’s brain and an external device. Monitoring brain activity in a virtual reality setting with feedback also allows for collecting valuable data with a range of potential implementations, from brain-controlled games to post-stroke rehabilitation and recovery. Although the technology has been around for decades, the recent solutions brought the increasing ease of use on one side and dwindling costs of use on the other, allowing it to enter the day-to-day lives of a growing number of people. As a result, the number of potential applications has swelled and EEG monitoring is no longer a preserve of clinicians and expert neuroscientific researchers. For example, EEG allows applications of neuroscience methods to explore cognitive processes that are believed to drive consumer behavior. Over the past decade, marketing research has adopted neuroscience techniques to unveil conscious and unconscious consumer behavior drivers. The market for neuromarketing is expected to grow at a CAGR of 8.89% during 2021-2026, increasing from $1.2 billion in 2020 to 1.9 billion by 2026 (https://ibn.fm/W3JUi). Often, EEG is the technique of choice in consumer neuroscience research due to its low cost and high temporal resolution (https://ibn.fm/sE8PX). Brain monitoring technology is also deployed in the business environment, where it attempts to analyze employees’ brain activity to develop data-driven predictions or streamline business processes to boost efficiency and quality of the work. Nazarova further points out that as the industry matures, players are moving away from universal products to create more niche solutions. These solutions are designed for specific tasks such as attention-tracking or memory improvement, boosting the demand for white-label EEG solutions. EEG monitoring is also expected to find further applications in providing businesses with science-backed evidence. This application could be especially helpful for companies seeking to demonstrate to consumers the efficacy of their products. With this goal in mind, it could be deployed across several fields such as meditation, sport, education, and arts, where it could help document users’ brain activity as a response to certain products. Finally, telemedicine is another application field where neurofeedback and biofeedback platforms have been appearing on the market. Exciting new opportunities are potentially in front of EEG technology. EEG-based products go beyond the medical space and are on their way to penetrate new sectors and find more uses. Brain Scientific is committed to remaining a key innovative leader in what could potentially be a rapidly growing market over the next years. For more information, visit the company’s website at www.BrainScientific.com/Invest-Now. NOTE TO INVESTORS: The latest news and updates relating to BRSF are available in the company’s newsroom at https://ibn.fm/BRSF

• The live streaming music industry is expected to reach $76.9 billion by 2027
• The current customer reach is documented at 42.7 million, a year-over-year rise of close to 50%
• Fan Pass provides various streams of revenue for artists by giving them a virtual stage where they can earn on live event ticket sales, video content views, merchandise sales, and artist contests.
• The first anniversary (July 24, 2021) will be the release of the new 2.0 version of the platform

The global live streaming music industry has increased significantly in the last year and is expected to continue with an upward growth trend in the coming years, as demand continues to grow, and more platforms emerge in the market. The industry was valued at $20.9 billion in 2019 and $24.4 billion in 2020. The expectation is that the market will reach $76.9 billion by 2027, growing at a CAGR of 17.8% during the forecast period (2020-2027). Due primarily to the pandemic, the number of customers who pay for online music has reached 42.7 million, a year-over-year rise of nearly 50% (https://ibn.fm/HdfUV). Mobile technology and marketing company Friendable (OTC: FDBL) and its proprietary Fan Pass platform are disrupting the live streaming industry, changing how fans view their favorite artists – online and eventually in-person. For almost a year, Fan Pass has been turning the live streaming industry into a place where artists can truly earn revenue on ticketed online concerts, merch sales, and on-demand video content. Even with venues beginning to open around the world, Fan Pass has not lost any momentum – artist signups grow month after month and the platform is set to launch its 2.0 version on its one-year anniversary (July 24). The Fan Pass platform enables artists to earn through various avenues, including:

• Content Views: Artists on the Fan Pass platform receive up to 40% of the $3.99 per month subscription paid by fans every month based on the content views
• Merchandise Sales: Artists earn 50% of all net revenue from merchandise sales
• Ticket Sales: Artists who schedule online concerts and sell tickets to the event, keep 100% of the amount charged for each ticket

In the coming months, artists will also be able to earn additional revenue through the platform using non-fungible tokens (“NFTs”). The company has already signed a Letter of Intent with Santo Blockchain Labs and Santo Mining Corp. (OTC: SANP) to develop global entertainment and musical artist-driven NFTs. Each month, Friendable and Fan Pass give artists additional ways of earning revenue through Artist Contests. These contests range in prizes, with the June contest offering the following rewards: 1st Place – $500 cash, 2nd Place – $250 cash, and 3rd Place – $150 cash. Additionally, the artist who sells the most merchandise will also win a custom merch package from the team. Friendable is also upgrading the Fan Pass shop’s offering for artists. Not only can artists take advantage of paying for Pro Services provided by the company for custom logo, merchandise, and marketing designs, but they can now shop streaming gear (https://ibn.fm/7wP0O). The Fan Pass streaming gear makes it possible for emerging artists to find their footing in the live streaming music industry. The offering includes:

• Audio Interface with DJ Mixer and Sound Card
• Donner 12-Pack Acoustic Foam Panels Wedges
• TONOR Microphone Isolation Shield, Studio Mic Sound Absorbing Foam Reflector
• Focusrite Scarlett 2i2 (3rd Gen)
• Audio-Technica ATH-M50X Professional Studio Monitor Headphones
• KRK Classic 5 Professional Bi-Amp
• GoPro HERO9 Black
• And so much more!

Currently implementing its 120-day strategy, which will extend through the end of 2021, Friendable focuses on dedicating and driving downloads to the mobile app and acquiring exclusive content, artist performances, ticket sales, fee-based services, fan subscriptions, and so on (https://ibn.fm/HhsWc). Commenting on the upcoming release of Fan Pass platform’s version 2.0, CEO Robert A. Rositano, Jr. voiced confidence that it “is going to blow our existing artists away and build a buzz through artist communities that will drive future growth, fan sign-ups, merchandise sales, and recurring revenue, all of which have been tested and proven at a micro level throughout our proof of concept and pilot phase.” For more information, visit the company’s websites at www.Friendable.com or www.FanPassLive.com. NOTE TO INVESTORS: The latest news and updates relating to FDBL are available in the company’s newsroom at http://ibn.fm/FDBL

• Global functional water market forecast to reach $158.28 billion in 2023
• Through its wholly owned subsidiary, Naturo Group, BevCanna offers full line of alkaline and plant-based mineral-infused waters within functional water market
• North American distribution network expanded significantly in recent weeks via agreements with Koyo Foods throughout Ontario and Quebec and Benefit Brand Management in populous U.S. cities
• In response to consumer demand for more options, BevCanna is launching new line of multi-packs for sale throughout Canada

There is always something on the market that health-conscious individuals crave to put in their body, whether it has anecdotal or clinical rationale behind it. Amid healthier trends away from sugary drinks, functional water continues to grow in popularity, and BevCanna Enterprises’ (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Naturo Group is there to provide, offering its “TRACE” lineup of alkaline and mineral-infused water products sourced from the company’s pristine alkaline spring water aquifer in British Columbia. On the back of two new distribution deals, the North American retail network for TRACE products just got significantly bigger, for which the company responded with a new multi-pack options for consumers. Alkaline waters, those with a pH between 7.1 – 9.9, are believed to deliver many health benefits, including boosting immunity. Mineral-infused water goes by several names, including black water, mineralized fulvic and humic spring water, and ionic mineral water and contains dozens of naturally occurring minerals essential to health. Proponents contest that there is no scientific evidence that either type of water conclusively helps the body, but the global functional water market forecast to reach $158.28 billion in 2023 tells a different story about what consumers think (https://ibn.fm/aDRAr). Ahead of the deals, BevCanna’s distribution network already spanned over 3,000 retail locations and online at www.mytracewellness.com, giving TRACE a strong start to compete for market share. Early in June, Naturo struck a deal with Koyo Foods, one of the largest health food distributors in Eastern Canada, to add the TRACE line to its portfolio of reputable brands, like Earths Own, Thirsty Buddha, and Gusta Artisanal Vegan, to its retailers across Ontario and Quebec. The response was immediate, with Koyo confirming that “a number of retailers” had already placed orders for TRACE (https://ibn.fm/GZGio). In the U.S., BevCanna inked a distribution agreement with Benefit Brand Management, a leader wholesaler of natural products. This new pact is starting out with Benefit Brand placing TRACE products at an array of U.S. retailers, including independent natural and specialty retailers and big box retailers, starting in New York, Chicago and select cities in California (https://ibn.fm/HFUne). Currently, all the TRACE waters are sold in individual plastic and/or aluminum cans ranging in size from 355 mL to 4 L. In response to consumer demand for take-home and value-priced options, BevCanna is launching new TRACE multi-packs in national retailers across Canada. The increased distribution and new packaging options speak to the success of BevCanna’s expert sales team, led by VP of Sales and Insights Raffael Kapusty and VP of Sales and Sales Operations Bill Niarchos. Kapusty and Niarchos are seasoned consumer package goods veterans that were instrumental in signing the Koyo and Benefit Brand deals, amongst others that are spreading TRACE products across the continent. “We’re pleased that consumer demand for the TRACE line of alkaline and mineral-infused water products has taken off so quickly,” said Melise Panetta, President of BevCanna. “The addition of the new multi-pack options reflects the very positive response we’ve seen in the Canadian marketplace to our wellness-focused range of products,” she added. BevCanna manufactures TRACE products in Canada from its state-of-the-art 40,000 square foot HACCP certified facility. It also performs white label production services, which are expected to generate at least $2.4 million in revenue based upon the first three contracts, a nice complement to corporate coffers while TRACE distribution continues to expand. The company still has plenty of headroom to keep growing considering the facility has capacity of 210 million bottles per annum. For more information, visit the company’s website at www.BevCanna.com. NOTE TO INVESTORS: The latest news and updates relating to BVNNF are available in the company’s newsroom at http://ibn.fm/BVNNF

• According to CEO Evan Gappelberg, Nextech is the only diversified small-cap company participating in the rapidly growing digital transformation
• The company is ideally positioned to capitalize on the rapid market adoption environment accompanying the ongoing evolution of AR-led technology
• A recently released report by Facebook shows that a majority of companies will adopt AR and VR technologies in the coming years and that spending on these technologies will increase sixfold by 2024
• This report augurs well for Nextech’s operations as the company, which already has existing AR solutions, is driving market-wide AR-adoption

As the business world undergoes a paradigm shift forcing more and more companies to embrace and implement digital transformation, technology juggernauts are leading the way by offering cloud computing, streaming, e-commerce, networking, video conferencing, augmented reality (“AR”), and virtual reality (“VR”) services and infrastructure. But this role is not the reserve of such behemoths, especially because Nextech AR Solutions (CSE: NTAR) (OTCQB: NEXCF), a diversified small-cap company, is participating in the rapidly growing digital transformation. The company, which is one of the leaders in the rapidly growing AR industry, is capitalizing on the fact that the major catalysts for AR and VR adoption, i.e., the 5G network whose installation is ongoing in multiple countries around the world and AR-capable consumer wearable devices that hitting the market, are already in place. In a presentation to investors during the Virtual Investor Conferences, Nextech Founder & CEO Evan Gappelberg noted that the world is currently experiencing the fourth industrial revolution, which is prompting technological evolution at a pace never before seen (https://ibn.fm/NqqJZ). “This evolution is being led by AR, AI, Internet of Things (“IoT”), edge computing and the 5G network, all of which are converging and becoming increasingly ubiquitous for training, e-commerce, advertising, and entertainment,” the presentation reads. “This convergence is stimulating a rapid market adoption environment similar to the internet in the 1990s, driving the creation of billion-dollar industries almost overnight, a market Nextech is uniquely positioned to capitalize on.” In a new volume of its quarterly Hello Future report series (https://ibn.fm/EYpNB), Facebook corroborates Evan’s sentiments. The report, which augurs well for Nextech’s operations, notes that the importance of AR and VR in people’s everyday lives will grow in the near future; people are welcoming AR into their lives – 78% of people around the world say AR is a fun way to interact with brands and 74% believe AR can bridge the gap between online and offline. It also notes that 75% of business leaders expect to be using AR or VR by 2023 and projects that 2020’s spending on AR and VR will grow sixfold by 2024. In its analysis, the report states that AR and VR could revolutionize how people engage with brands and how brands engage with people by bridging the gap between online and offline shopping – it allows customers to try, explore, and digitally overlay products into real environments. And that AR and VR are making the world more efficient and equal, thanks to their impact on multiple sectors, including education and medicine. “The appeal is definitely growing in multiple markets across the globe. This is a clear indication that unique and interactive tech platforms will play a big role in the future and provide businesses with a plethora of exciting ways to interact with their customers,” observes a Digital Information World (“DIW”) article discussing the Facebook report (https://ibn.fm/66IDt). Although the statement by DIW tells of the future, Nextech, through its existing unique and interactive solutions, already plays a key role and is providing businesses, students, event organizers, event attendees, and instructors with a plethora of exciting ways to interact. For instance, multiple organizers have selected its Virtual Experience Platform (“VXP”) to host virtual events, while Ryerson University, Carnegie Mellon University, and other higher education institutions are already using its newly launched EdTechX platform (https://ibn.fm/s2mHQ). Moreover, the company offers AR-based solutions for e-commerce. While the DIW article regards AR and VR technologies as being in their infancy, Nextech is already participating in digital transformation by driving market-wide AR adoption. What’s more, its solutions are benefiting its clients by increasing measurable ROI, brand loyalty, online sales, and product awareness. For more information, visit the company’s website at www.NextechAR.com. NOTE TO INVESTORS: The latest news and updates relating to NEXCF are available in the company’s newsroom at https://ibn.fm/NEXCF

• Asia Broadband, an experienced producer of precious metals, is in the process of adding key gold mine property acquisitions in Mexico
• The company’s approach to metals sales to primarily Asian markets includes development of a cryptocurrency exchange with a token backed by its gold holdings
• Asia Broadband’s AABBG token will be traceable through the proprietary exchange for currencies such as Bitcoin, Ethereum and Litecoin, and will also be able to acquire value on principles of limited production and rising demand
• The company recently reported its enthusiasm over preliminary assay results on rocks taken at random throughout a mine in Nayarit that is subject to an LOI
• Asia Broadband is also working to increase shareholder value through agreements to retire some third-party shares

Precious metals resource holder and cryptocurrency developer Asia Broadband (OTC: AABB) is pressing forward with its efforts to acquire new gold reserves in Mexico, and announced May 25 that one of the mines subject to its letter of intent (“LOI”) has produced high-grade rock sample assay results from specimens collected at random throughout the property when due diligence procedures began. The preliminary report on the sample assay from the Acaponeta-Bonanza project increases the company’s hopes of obtaining high-grade mineralization values and vein concentrations throughout the property once an acquisition agreement is finalized. In addition, Las Vegas-based Asia Broadband has $30 million in gold held in reserve to provide backing to its cryptocurrency, which it launched in March as the AABBG token. The company has been assessing several gold mine projects since the beginning of the year, and has issued LOIs for mines and processing facilities in the states of Jalisco and Nayarit with a view of adding to its gold holdings under its mine-to-token strategy (https://ibn.fm/eVRYz). The Acaponeta project in Nayarit has two mine sites, existing infrastructure and a 200 ton-per-day processing facility located in a prolific mining region. The random rock samples included findings of 10.4 grams per ton (g/t), 8.9 (g/t) and 6.8 (g/t) of gold, according to the May 25 announcement (https://ibn.fm/cXn7R). Asia Broadband anticipates the potential acquisition will “expeditiously advance AABB into production and an expansion program,” according to the announcement. The company is intent on establishing a proprietary cryptocurrency exchange, which it expects to test in August and then launch in September. The company has been completing its cold wallet, web interfaces, transaction fee mechanism, trade platform and reporting system. Sales of the AABBG token have netted about $1.5 million in cryptocurrencies since March. The token’s value will be tethered to the existing price of one-tenth (0.1) gram of gold but the exchange will allow the token to achieve price appreciation beyond the minimum spot price supported by the gold reserve (https://ibn.fm/KYNPu), according to demand. The exchange will primarily make it possible for AABB Wallet users to complete quick two-way exchanges of their tokens for major cryptocurrencies such as Bitcoin, Ethereum and Litecoin. In a bid to increase shareholder value, the company completed agreements with some third parties to retire their shares for a return of 107 million restricted common shares to the company treasury, according to an announcement May 27 (https://ibn.fm/JZXUu). Asia Broadband expects to retire additional shares in the coming weeks to continue to build shareholder value. The company’s executive management team states Asia Broadband is in a highly liquid financial position to self-fund and is prepared to rapidly advance its business segments focused on mining and crypto creation (https://ibn.fm/BmTH0). It recorded an annual gross profit of $16.8 million at the end of the 2020 fiscal year (https://ibn.fm/S1T7O). For more information, visit the company’s website at www.AsiaBroadbandInc.com. NOTE TO INVESTORS: The latest news and updates relating to AABB are available in the company’s newsroom at https://ibn.fm/AABB

• Earlier this year, Grapefruit was approached by a Canadian cannabis company about a potential acquisition
• A series of events have delayed the process
• Final decisions, details should be discussed in the next 30–60 days

Grapefruit USA (OTCQB: GPFT), a premiere, fully licensed, California-based cannabis company, is providing clarification regarding its previously announced potential acquisition transaction by a Canadian cannabis company (https://ibn.fm/mymt2). Earlier this year, Grapefruit announces that it had been approached by a Canadian cannabis company to enter into discussions concerning a potential acquisition transaction (https://ibn.fm/LShI3). At the time, Grapefruit CEO Bradley J. Yourist noted that “Grapefruit is not surprised to be approached concerning a potential acquisition, in light of the company’s recent disclosure concerning its 714% year-over-year revenue increase; the public reaction to the company’s patented, disruptive Hourglass(TM) THC/cannabinoid delivery cream; and recent announcements by U.S. Senate Majority Leader Chuck Schumer concerning prioritization of the federal legalization of cannabis by de-scheduling THC.” Following that initial announcement, Grapefruit issued a series of follow-up announcements noting further progress of the potential acquisition, including the development of a memorandum of understanding (“MOU”) that sets forth terms under which the parties could enter into a joint venture to jointly manufacture, distribute and market Grapefruit’s products (https://ibn.fm/o39cc) as well as an announcement that the Canadian partner had scheduled a special shareholder’s meeting to consider the proposed joint venture and other corporate matters (https://ibn.fm/lT09w). At the shareholder meeting, the Canadian partner’s shareholders elected new directors and approved the acquisition of a Canadian-based hemp cultivator. Those actions triggered a change in control of the Canadian partner; as a result, the company had to submit new filings to the Canadian Stock Exchange and the formal joint venture agreement and further acquisition discussions were postponed pending acceptance of the filing by the CSE, which the Canadian partner expects in the very near future. “While Grapefruit was, of course, disappointed by the delays occasioned by our counterpart’s corporate action (which were in progress before our discussions commenced), we believe it was in the best long-term interests of Grapefruit and its shareholders to accept a pause while the Canadian partner concluded its corporate actions,” Yourist said. “Now we move forward. “As we have stated before, a joint venture may precede without precluding an acquisition. Execution of the MOU moved the entire process forward as we now more clearly understand each other’s overall goals and priorities as well as the capital requirements and legal, regulatory and logistical challenges of finalizing a joint venture and/or an acquisition,” Yourist continued. “We expect to bring the process forward to the point of making a decision in the next 30–60 days. Once again, that being said, we wish to emphasize that the discussions reported here, although substantive and largely positive, remain preliminary in nature and may be terminated at any time. Grapefruit will update the public as necessary on any material joint venture or acquisition developments as events proceed.” Grapefruit holds California permits and licenses to both manufacture and distribute cannabis products in the Golden State. The company’s extraction laboratory and manufacturing and distribution facilities are located in the industry-recognized Coachillin’ Industrial Cultivation and Ancillary Canna-Business Park in Desert Hot Springs, located on the extension of North Canyon Road, approximately 14 miles north of downtown Palm Springs. Grapefruit’s flagship product — Hourglass time-release delivery cream — features cutting-edge science and technology that solves the age-old problem of THC and other cannabinoids not being easily absorbed through the skin. The topical cream uses patented microsized particles to slowly deliver THC and a wide range of cannabinoids through skin topical administration. No other topical cream product on the market provides users with the holistic benefits of the range of cannabinoids found in Hourglass. To find out more about the company and its game-changing Hourglass time-release cannabinoid delivery cream, please visit www.GrapefruitBlvd.com. NOTE TO INVESTORS: The latest news and updates relating to GPFT are available in the company’s newsroom at https://ibn.fm/GPFT

• Ideanomics completed the acquisition of US Hybrid, a manufacturer and distributor of electric powertrain parts and fuel cell engines for medium and heavy-duty vehicles
• IDEX paid an aggregate purchase price of $50 million in cash and stock considerations
• The acquisition marked IDEX’s entry into the burgeoning EV powertrain market, which is expected to grow at a CAGR of 16% from 2020 to 2027
• The growth is due to several favorable factors that also bode well for the operations of IDEX and US Hybrid
• Ideanomics also announced that US Hybrid had received orders from Global Environment Products (“GEP”) for a fleet of all-electric street sweepers

Ideanomics (NASDAQ: IDEX) entered 2021 with the expectation that it would be yet another growth year. The company, which started the year by completing the acquisition of Wireless Advanced Vehicle Electrification (“WAVE”) and Timios, continued seeking new investments and acquisitions in revenue-based opportunities that would complement its existing operations segmented into two divisions – Ideanomics Mobility, dealing with electric vehicle (“EV”) business, and Ideanomics Capital, focusing on fintech. Early this month, Ideanomics added yet another company to its growing list of wholly owned subsidiaries when it completed the acquisition of 100% of privately held US Hybrid, a manufacturer and seller of electric powertrain parts and fuel cell engines for medium and heavy-duty municipality vehicles, commercial trucks, buses, and specialty cars (https://ibn.fm/YiciM). Expected to bring synergistic benefits to the various companies under the Ideanomics Mobility umbrella, the acquisition of US Hybrid is on the heels of a report by Market Research Future (“MRFR”), which anticipates the EV powertrain market to grow at a 16% CAGR between 2020 and 2027, reaching $135 billion (https://ibn.fm/pwI00). This projected growth is buoyed by several favorable factors that also bode well for the operations of both IDEX and US Hybrid. These include:

• An increase in the demand, production, and sales of EVs
• Improving EV infrastructure in multiple countries
• Stringent government regulations
• The burgeoning need for energy-efficient drivetrain systems
• The increasing adoption of electric powertrains in commercial vehicles
• Growing demand for electric powertrains in city trucks

Perhaps indicative of the burgeoning need and demand for energy-efficient electric drivetrain systems and cars, in line with the MRFR report, Ideanomics also announced that US Hybrid had received orders from Global Environment Products (“GEP”) for a fleet of all-electric street sweepers to deploy in various cities in the US and around the world. GEP, a manufacturer of specialized, purpose-built, heavy-duty, and reliable street cleaning equipment, and US Hybrid already have an existing partnership that has led to the delivery of many clean street sweepers to clients in the US and Japan. And although the current order is simply an extension of this partnership, it is expected to add more than $1 million in revenue to US Hybrid’s balance sheet for the current financial year. Each new, all-electric street sweeper will feature one 120-kW traction motor and lithium-ion batteries charged via an AC 20kW, SAE J1772-compliant charging system. Further, each sweeper is expected to save approximately 89 metric tons of carbon emission over the vehicle’s lifetime, equivalent to taking a total of 19 cars off the road for a whole year. “We welcome Dr. [Gordon Abas] Goodarzi and his entire team to Ideanomics and are confident they will bring tremendous knowledge, innovation, and value to the company in addition to their synergistic alignment with many of our existing subsidiary brands,” said IDEX CEO Alf Poor. “I look forward to the accelerated commercialization and innovation US Hybrid will bring to Ideanomics’ ecosystem. It will benefit businesses, communities around the world, and more importantly, our planet.” On his part, Dr. Goodarzi, Ph.D., PE, the CEO of US Hybrid, said: “Ideanomics has emerged as a true powerhouse in the commercial EV sector with a synergistic ecosystem of technologies and solutions that covers the entire value chain of electrification. We look forward to leveraging that strength going forward.” For more information, visit the company’s website at www.Ideanomics.com. NOTE TO INVESTORS: The latest news and updates relating to IDEX are available in the company’s newsroom at https://ibn.fm/IDEX

• WTER 2020 FY revenues make company largest alkaline water company in the U.S.
• In addition, the brand is one of the top-10 largest enhanced water brands in the country
• Research shows that Alkaline88 has the greatest brand loyalty among alkaline water drinkers

With its most recent financial report, The Alkaline Water Company (NASDAQ: WTER) (CSE: WTER) is now the largest independent alkaline water company in the nation, having reported 2020 FY revenue of $41.1 million, which represents a 28% increase year over year. Leading the pack is an impressive accomplishment, especially when the market is projected to reach $1 billion in 2022 (https://ibn.fm/wjAhh). WTER has shown consistent growth since the release of its flagship product: Alkaline88(R). Alkaline88 ionized water contains only two ingredients — water and Pink Himalayan rock salt — and has built a reputation for superior hydration with a perfect 8.8 pH balance. The brand was formulated to offer a smooth taste that encourages consumers to drink more and fully hydrate, key factors in maintaining health and wellness. Alkaline88 is now available in more than 75,000 retail stores nationwide, and in addition to being number one in the indie alkaline water space, the brand has captured a prestigious spot as one of the top-10 largest enhanced water brands in the country as well. As per Nielsen data, the brand is the only top-10, nonflavored, value-added water brand that has consistently grown double digits in both units and dollar volume every four-week period since the end of 2019. In addition, research indicates that Alkaline88 has the greatest brand loyalty among alkaline water drinkers. “The brand awareness and newfound loyalty during COVID-19 was best exemplified by independent data that showed 31% of the people who drank Alkaline88 during the 52-week period ended March 6, 2021, were first-time buyers,” reported a recent article (https://ibn.fm/s1OFI). The same research showed that 47% of purchases of Alkaline88 in the last year are from consumers who have bought it four or more times. “Part of the reason for the loyalty likely has to do with the social culture of The Alkaline Water Co.,” the article continued. “Millennials and younger generations are passionate about ethos and factor that into decision making about purchases. The company adheres to the strictest industry guidelines set forth by individual states, FDA, EPA and International Bottled Water Association. It has retooled its ionization system to use less water and electricity and was the first national company in the industry to offer eco-friendly aluminum packaging options.” In addition to its flagship Alkaline88 brand, the company launched A88 Infused(TM) in 2019 to meet consumer demand for flavor-infused products. A88 Infused flavored water is available in six unique naturally flavored options. Additionally, in 2020, the company announced its A88 Infused Beverage Division Inc., which includes the company’s CBD water and flavor-infused water. For the company’s topical and ingestible offerings, A88 Infused Products includes both the company’s lab-tested hemp extract salves, balms, lotions, essential oils and bath salts, powder packs, oil tinctures, capsules and gummies. For more information, visit the company’s website at www.TheAlkalineWaterCo.com and www.a88CBD.com. NOTE TO INVESTORS: The latest news and updates relating to WTER are available in the company’s newsroom at http://ibn.fm/WTER

• Collaboration will use TumorGenesis’ expertise in cancer cell culture growth media in combination with Cellevate’s specialty in emerging field of nanofiber matrixes.
• Cutting-edge technology can help avoid mistakes in $2.6 billion process of bringing new drugs through FDA process.
• Coupling companies’ technology will give researchers ability to grow ovarian cancer tissues in 3D matrix support system with right media for right ovarian cancer cell types

Getting a drug through the complete FDA process, from pre-clinical to approval, is an arduous and expensive task, although there are signs that approval rates are accelerating after years of decline. Companion diagnostics, new approaches and technology are playing important roles in increasing the chances of a drug’s success from the outset—a fact not lost on stakeholders when making investment decisions (https://ibn.fm/t4SkS). Raising the success rate for experimental cancer drugs starts in the laboratory, where leading-edge technology could be instrumental in providing prescient insights that ultimately result in better clinical outcomes. Looking to give oncology drug developers an upper hand, TumorGenesis, a subsidiary of Predictive Oncology (NASDAQ: POAI), has partnered with Swedish cell culture system company Cellevate AB for the purpose of combining TumorGenesis’ medias with Cellevate’s high engineered matrix materials (https://ibn.fm/ftoee). More specifically, the collaboration will involve using TumorGenesis expertise in cancer cell culture growth media in combination with Cellevate’s specialty in the emerging field of nanofiber matrixes. The initial indication for the partners is ovarian cancer, the fifth most deadly type of cancer in women in the U.S. and leading cause of death amongst cancers of the female reproductive system (https://ibn.fm/0Ukpr). The goal is to bring researchers the next generation of tools for hard-to-treat diseases. Armed with new tech, drug developers can aim to avoid early mistakes related to selecting the wrong target based on cancer cell lines. Missteps contribute to the already exorbitant cost of drug development, a figure estimated at $2.6 billion by Tufts Center for the Study of Drug Development (https://ibn.fm/gAxOG). Cells in Cellevate’s nanofibers networks are allowed to proliferate and interact with other cells in three dimensions (“3D”), in contrast to the monolayer cultures seen on conventional two-dimensional (“2D”) surfaces. TumorGenesis technology facilitates ex-vivo (outside the body) ovarian cancer cell and tumor growth that mimics that of the patient. The partnership provides new opportunities for both companies. It further represents an expansion of the Predictive Oncology product portfolio into an area it hadn’t addressed before. “This combination will give researchers the ability to grow ovarian cancer tissues in a 3D matrix support system with the right media for the right ovarian cancer cell types,” commented Richard Gabriel, SVP of Research & Development at Predictive Oncology. Parent to a family of companies, Predictive Oncology is focused on applying data and artificial intelligence to cancer personalized medicine and drug discovery. “By combining the strength and expertise of our organizations we believe that we can bring something truly unique and valuable to the market,” commented Cellevate CEO Maximilian Ottosson. POAI is bringing precision medicine, or tailored medical treatment using the individual characteristics of each patient, to the treatment of cancer. Through its Helomics division, the company leverages its unique, clinically validated patient derived (“PDx”) smart tumor profiling platform to provide oncologists with a roadmap to help individualize therapy. In addition, the company is leveraging artificial intelligence and its proprietary database of over 150,000 cancer cases tumors to build AI-driven models of tumor drug response to improve outcomes for the patients of today and tomorrow. For more information, visit the company’s website at www.Predictive-Oncology.com. NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI

Date: June 22-24, 2021 Virtual Event The 11th Annual Medical Device Strategic Pricing & Accounts Conference is being held from June 22-24, 2021, at Q1 Productions dynamic virtual platform. Companies, representatives, and professionals from the Medtech industry are invited to attend this virtual event. Operating since 2006, Q1 Productions specializes in delivering educational programming through its curated conferences and research-based events. The official sponsor of this conference is PROS, an AI-powered commerce platform offering personalized customer experience solutions to MedTech companies, in addition to networking sponsor Charles River and Associates, and bronze sponsor ZS Pharma. The 3-day virtual conference will witness keynote panel discussions, fireside chats, and group discussions where participants will get in-depth insights into the industry practices to regulate and control the pricing of the medical device landscape. The conference has 3 major modules distributed over three days and eminent MedTech industry veterans will facilitate and offer their invaluable opinions on the various topics outlined in the agenda of the conference. Some important topics and discussions covered in the Conference include:

• Assessment of policy changes for the purchase and pricing of medical devices during the Biden administration
• Developing a harmonious value proposition between the traditional practices as well as the evolving health care market
• Roadblocks encountered due to the impact of the pandemic that has increased the need for virtual interactions
• Growth of the Medtech sector during the pandemic
• Use of AI for a better buying and selling experience of the consumer
• Building a culture of ethics and compliance parameters that must be considered for contract negotiations
• Discussions with GPOs, IDNs, and manufacturers, to prepare pricing and enterprise sales teams for upcoming healthcare challenges
• Addressing the impact of outpatient center needs on hospital revenue generation and the impact on supplier & provider processes
• Contemporary improvements to the Medtech pricing model
• Impact on performance-based pricing due to COVID-19

The conference modules cover all aspects of medical device strategic pricing serving as a complete Medtech pricing learning guide for newbies and established companies in the medical device segment. For more details regarding the event, please visit https://ibn.fm/8X32c